LEVI-04

N/A

Report date: 2026/03/31 20:00:21

Base Information

Drug NameLEVI-04
Drug Alias NameLEVI-04p75NTR-Fc
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionNeurotrophin-3 inhibitors
TargetsNeurotrophin-3
Therapy Area/IndicationsPainRheumatic DiseasesOsteoarthritis, Knee +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaUnited StatesPoland +[6] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesLevicept
China Registration ClassN/A

Develop Information

Active CompaniesLevicept
Inactive CompaniesN/A
Active IndicationsPainRheumatic DiseasesOsteoarthritis, Knee +[6] 
Inactive IndicationsMusculoskeletal Diseases

Other Information

ATC CodeN/A
Related LinksN/A